Daniel Duncan, MD, MPH

Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition
Assistant Professor of Pediatrics, Harvard Medical School
Image
Daniel Duncan, MD, MPH

Daniel Duncan, MD, MPH

Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition
Assistant Professor of Pediatrics, Harvard Medical School
Education
Medical School
Yale School of Medicine
New Haven
CT
Residency
Boston Combined Residency Program (BCRP)
2015
Boston
MA
Fellowship
Pediatrics GI/Nutrition
Boston Children's Hospital
2018
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Gastroenterology)
Safe Zone Trained

Publications

A prospective study of diagnostic testing and hospital charges after brief resolved unexplained event. View Abstract
Outcomes for infants with BRUE diagnosed with oropharyngeal dysphagia or gastroesophageal reflux disease: a multicenter study from the Pediatric Health Information System Database. View Abstract
Brief Resolved Unexplained Events Symptoms Frequently Result in Inappropriate Gastrointestinal Diagnoses and Treatment. View Abstract
Breastfeeding in infants who aspirate may increase risk of pulmonary inflammation. View Abstract
Pediatric Aerodigestive Medicine: Advancing Collaborative Care for Children With Oropharyngeal Dysphagia. View Abstract
A Prospective Study of Parental Experience with Thickening Feeds for Children with Oropharyngeal Dysphagia and Gastroesophageal Reflux. View Abstract
Gastrointestinal factors associated with risk of bronchiectasis in children. View Abstract
A Prospective Study of Brief Resolved Unexplained Events: Risk Factors for Persistent Symptoms. View Abstract
Low diagnostic yield in BRUE hospitalization. View Abstract
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12?139 Cancer Patients. View Abstract
Evaluating the adherence to national guidelines for treatment of gastroesophageal reflux in infants. View Abstract
JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology. View Abstract
Acid Suppression Does Not Improve Laryngomalacia Outcomes but Treatment for Oropharyngeal Dysphagia Might Be Protective. View Abstract
Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma. View Abstract
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas. View Abstract
Overlapping Symptoms of Gastroesophageal Reflux and Aspiration Highlight the Limitations of Validated Questionnaires. View Abstract
Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma. View Abstract
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer. View Abstract
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. View Abstract
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response. View Abstract
Clinical Aspects of Thickeners for Pediatric Gastroesophageal Reflux and Oropharyngeal Dysphagia. View Abstract
The Impact of the American Academy of Pediatrics Brief Resolved Unexplained Event Guidelines on Gastrointestinal Testing and Prescribing Practices. View Abstract
Feeding Interventions Are Associated With Improved Outcomes in Children With Laryngeal Penetration. View Abstract
Association of Proton Pump Inhibitors With Hospitalization Risk in Children With Oropharyngeal Dysphagia. View Abstract
Presenting Signs and Symptoms do not Predict Aspiration Risk in Children. View Abstract
Oropharyngeal Dysphagia Is Strongly Correlated With Apparent Life-Threatening Events. View Abstract
Gastroesophageal Reflux Burden, Even in Children That Aspirate, Does Not Increase Pediatric Hospitalization. View Abstract
TGFßR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts. View Abstract
Was that last colonoscopy really negative? A surprising cause of rectal bleeding in a 75-year-old man. View Abstract
Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. View Abstract
Challenges in translating vascular tissue engineering to the pediatric clinic. View Abstract
Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. View Abstract
A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. View Abstract
Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI. View Abstract
Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. View Abstract
Cell-seeding techniques in vascular tissue engineering. View Abstract
A novel mutation in two families with limb-girdle muscular dystrophy type 2C. View Abstract